Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,729,739
-$198,285 QoQ
Shares Held
237,946
+12.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#558
of 2,821 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. PFE ranks #5 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
This page
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,729,739 | 237,946 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,928,024 | 211,112 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,248,646 | 210,789 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,518,956 | 255,846 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,036,875 | 249,046 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,432,794 | 214,396 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,290,692 | 199,423 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,153,309 | 212,623 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $5,641,411 | 201,623 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,941,663 | 214,114 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,755,811 | 199,924 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,759,259 | 233,924 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,331,641 | 227,144 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,327,035 | 204,094 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,665,657 | 169,119 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,531,927 | 172,119 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,206,917 | 175,604 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $9,165,050 | 177,034 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,615,052 | 162,829 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,712,975 | 132,829 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,770,823 | 121,829 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,942,874 | 108,829 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,907,825 | 51,829 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,718,622 | 46,829 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||